Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Blevins

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Drug and Alcohol Dependence Reports|May 26, 2023
State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirementsAnita Silwal, Jeffery Talbert, Robert M Bohler, et al.
Journal of Addiction Medicine|January 12, 2022
Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of PrescribersMinhee L Sung, Anne C Black, Derek Blevins, et al.
Journal of Addiction Medicine|October 30, 2024
Clinician and Practice Characteristics Associated With Support of Office-based Methadone: Findings From a National SurveyMinhee L Sung, Anne C Black, Derek Blevins, et al.
The International Journal on Drug Policy|May 28, 2025
System dynamics modeling to inform implementation of evidence-based prevention of opioid overdose and fatality: A state-level model from the New York HEALing Communities StudyNasim S Sabounchi, Rachel L Thompson, Matthew R Lootens, et al.
Journal of Substance Use and Addiction Treatment|November 27, 2025
The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trialCarrie B Oser, Joel G Sprunger, Tim Hunt, et al.
Drug and Alcohol Dependence|April 16, 2024
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trialLaShawn Glasgow, Christian Douglas, Joel G Sprunger, et al.
JAMA Network Open|February 22, 2024
Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing: A Prespecified Secondary Analysis of the HCS Randomized Clinical TrialThomas J Stopka, Denise C Babineau, Erin B Gibson, et al.
AJPM Focus|October 2, 2025
Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing?Frances R Levin, Douglas R Oyler, Denise C Babineau, et al.
Drug and Alcohol Dependence|July 20, 2025
Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trialJennifer L Brown, Marc R Larochelle, Laura C Fanucchi, et al.
The New England Journal of Medicine|June 17, 2024
Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths, Jeffrey H Samet, Nabila El-Bassel, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Drug and Alcohol Dependence Reports|May 26, 2023
State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirementsAnita Silwal, Jeffery Talbert, Robert M Bohler, et al.
Journal of Addiction Medicine|January 12, 2022
Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of PrescribersMinhee L Sung, Anne C Black, Derek Blevins, et al.
Journal of Addiction Medicine|October 30, 2024
Clinician and Practice Characteristics Associated With Support of Office-based Methadone: Findings From a National SurveyMinhee L Sung, Anne C Black, Derek Blevins, et al.
The International Journal on Drug Policy|May 28, 2025
System dynamics modeling to inform implementation of evidence-based prevention of opioid overdose and fatality: A state-level model from the New York HEALing Communities StudyNasim S Sabounchi, Rachel L Thompson, Matthew R Lootens, et al.
Journal of Substance Use and Addiction Treatment|November 27, 2025
The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trialCarrie B Oser, Joel G Sprunger, Tim Hunt, et al.
Drug and Alcohol Dependence|April 16, 2024
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trialLaShawn Glasgow, Christian Douglas, Joel G Sprunger, et al.
JAMA Network Open|February 22, 2024
Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing: A Prespecified Secondary Analysis of the HCS Randomized Clinical TrialThomas J Stopka, Denise C Babineau, Erin B Gibson, et al.
AJPM Focus|October 2, 2025
Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing?Frances R Levin, Douglas R Oyler, Denise C Babineau, et al.
Drug and Alcohol Dependence|July 20, 2025
Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trialJennifer L Brown, Marc R Larochelle, Laura C Fanucchi, et al.
The New England Journal of Medicine|June 17, 2024
Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths, Jeffrey H Samet, Nabila El-Bassel, et al.
Pageof 2